Trials / Completed
CompletedNCT05805579
Diaphragmatic Echography in COVID-19 Pneumonia
Prognostic Value of Transthoracic Diaphragmatic Echography in COVID-19 Pneumonia Patients With Acute Respiratory Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 171 (actual)
- Sponsor
- Javier Lázaro · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesized that diaphragm thickness is concerned in acute respiratory failure of COVID19 patients and its ultrasound measure at the begining of hospitalisation is a good predictor of poor outcome. A prospective observational non intervention study is designed.
Detailed description
To answer our hypothesis we will perform diaphragm ultrasound in the first 24hr hospitalized COVID19 patients. In the ultrasound exploration we will assess diaphragm movility and thickness. We will also assess other clinical, biochemistry and radiological variables. The main outcome we want to analyze is the destination on discharge: home, respiratory intermediate critical unit or exitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Diaphragmatic echography | Diaphragmatic echography |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2021-06-20
- Completion
- 2021-06-20
- First posted
- 2023-04-10
- Last updated
- 2023-04-10
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05805579. Inclusion in this directory is not an endorsement.